WC
UTHR icon

Weil Company’s United Therapeutics UTHR Stock Holding History

Weil Company’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2M Sell
3,697
-1,210
-25% -$681K 0.35% 55
2026
Q1 		$2.91M Sell
4,907
-335
-6% -$167K 0.65% 37
2025
Q4 		$2.55M Sell
5,242
-166
-3% -$77.3K 0.59% 44
2025
Q3 		$2.27M Buy
5,408
+207
+4% +$69.6K 0.55% 44
2025
Q2 		$1.49M Buy
5,201
+631
+14% +$189K 0.39% 54
2025
Q1 		$1.41M Buy
4,570
+3,298
+259% +$1.13M 0.42% 46
2024
Q4 		$449K Sell
1,272
-10,531
-89% -$3.87M 0.16% 75
2024
Q3 		$4.23M Sell
11,803
-2,002
-15% -$676K 1.39% 18
2024
Q2 		$4.4M Sell
13,805
-775
-5% -$205K 1.6% 18
2024
Q1 		$3.35M Sell
14,580
-5,853
-29% -$1.32M 1.33% 22
2023
Q4 		$4.49M Sell
20,433
-27,587
-57% -$6.36M 1.97% 11
2023
Q3 		$10.8M Sell
48,020
-246
-0.5% -$56.7K 5.39% 3
2023
Q2 		$10.7M Sell
48,266
-148
-0.3% -$32.8K 4.74% 3
2023
Q1 		$10.8M Buy
48,414
+1,341
+3% +$331K 4.92% 3
2022
Q4 		$13.1M Buy
47,073
+6,616
+16% +$1.67M 5.96% 4
2022
Q3 		$8.47M Buy
40,457
+2,974
+8% +$665K 5.2% 3
2022
Q2 		$8.83M Buy
37,483
+2,152
+6% +$437K 4.97% 3
2022
Q1 		$6.34M Buy
35,331
+12,699
+56% +$2.42M 3.19% 4
2021
Q4 		$4.89M Buy
22,632
+10,031
+80% +$1.97M 2.28% 7
2021
Q3 		$2.33M Buy
12,601
+3,318
+36% +$654K 1.21% 22
2021
Q2 		$1.67M Buy
9,283
+1,816
+24% +$346K 0.84% 34
2021
Q1 		$1.25M Buy
+7,467
New +$1.25M 0.71% 37

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Weil Company's UTHR Position: Q2 2026 in Review

Weil Company reduced its United Therapeutics (UTHR) stake by 25% in Q2 2026, selling an estimated $681K and leaving 3,697 shares worth $2M. The position accounts for 0.35% of the portfolio, ranked #55.

Weil Company first reported a position in UTHR in Q1 2021 and has held it in 22 quarters since. The position peaked at $13.1M in Q4 2022. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Weil Company held 3,697 shares of United Therapeutics worth $2M as of Q2 2026.
  • Weil Company sold 1,210 United Therapeutics shares in Q2 2026, an estimated $681K.
  • United Therapeutics made up 0.35% of Weil Company's portfolio in Q2 2026, its #55 holding.
  • Weil Company first reported a position in United Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • Weil Company's United Therapeutics position peaked at $13.1M in Q4 2022.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Weil Company's 13F filing for Q2 2026, filed 5 Aug 2026.